FDA approves new drug to fight prostate cancer<p>German drugmaker Bayer and its development partner Algeta won approval from U.S. regulators for a prostate cancer drug that could eventually generate more than 1 billion euros ($1.31 billion) in annual sales.</p><img src="http://feeds.feedburner.com/~r/foxnews/health/~4/A0TGCzqLJm8" height="1" width="1"/>
Source: FDA approves new drug to fight prostate cancer (http://feeds.foxnews.com/~r/foxnews/health/~3/A0TGCzqLJm8/)